Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.

被引：2
|
作者：
Hansen, Jean M.
Ring, Karl Lassen
Baggerly, Keith A.
Wu, Sherry
Timms, Kirsten
Neff, Christopher
Hughes, Elisha
Previs, Rebecca A.
Broaddus, Russell
Coleman, Robert L.
Lu, Karen H.
Sood, Anil
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Myriad Genetics Inc, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5584
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinical significance of homologous recombination deficiency score testing in endometrial Cancer
    Siedel, Jean H.
    Ring, Kari L.
    Hu, Wei
    Dood, Robert L.
    Wang, Ying
    Baggerly, Keith
    Darcy, Kathleen M.
    Conrads, Thomas P.
    Gallagher, Shannon
    Tshiaba, Placede
    Neff, Chris
    Timms, Kirsten M.
    Mangala, Selanere
    Westin, Shannon N.
    Broaddus, Russell
    Lopez-Berestein, Gabriel
    Coleman, Robert L.
    Lu, Karen H.
    Maxwell, George L.
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (03) : 777 - 785
  • [2] Homologous recombination deficiency score testing in endometrial cancer
    Hansen, J. M.
    Ring, K.
    Hu, W.
    Dood, R. L.
    Wang, Y.
    Baggerly, K. A.
    Gallagher, S.
    Tshiaba, P.
    Neff, C.
    Timms, K. M.
    Mangala, L. S.
    Westin, S. N.
    Broaddus, R.
    Lopez-Berestein, G.
    Lu, K. H.
    Coleman, R. L.
    Maxwell, G. L.
    Sood, A. K.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 225 - 225
  • [3] Stochasticity in threshold of homologous recombination deficiency (HRD) score.
    Xu, Bai
    Xu, Bai
    Kai, Zhentian
    Thi, Phuong Anh Nguyen
    Xia, Chaoran
    Shi, Weiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17561 - E17561
  • [4] Homologous recombination deficiency (HRD) testing on ovarian cancer ascites: A feasibility study
    Ranghiero, A.
    Rocco, E. Guerini
    Rappa, A.
    Varcica, D.
    Taormina, S. V.
    Adorisio, R.
    Marinucci, L.
    Betella, I.
    Aletti, G.
    Colombo, N.
    Fusco, N.
    Casadio, C.
    Di Tonno, C.
    Barberis, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S717 - S717
  • [5] Homologous recombination deficiency (HRD) score and niraparib efficacy in high grade ovarian cancer
    Haluska, P.
    Timms, K. M.
    AlHilli, M.
    Wang, Y.
    Hartman, A. M.
    Jones, J.
    Gutin, A.
    Sangale, Z.
    Neff, C.
    Lynchbury, J.
    Rudolph-Owen, L.
    Becker, M. A.
    Agarwal, S.
    Wilcoxen, K. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 72 - 73
  • [6] The clinical value of homologous recombination deficiency score in prostate cancer
    Wang, Yan
    Qu, Min
    Dong, Zhenyang
    Hao, Qing
    Lin, Guomin
    Song, Jinyi
    Gao, Xu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Homologous recombination deficiency (HRD) in patients with pancreatic cancer (PC) and response to chemotherapy
    Shahda, Safi
    Timms, Kirsten
    Ibrahim, Ashley
    Reid, Julia E.
    Cramer, Harvey M.
    Radovich, Milan
    Ibrahim, Sulfikar
    Allen, Brian
    O'Neil, Bert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Clinical Utility of Homologous Recombination Deficiency (HRD) Profiling in Ovarian Cancer: An Indian Experience
    Bahadur, U.
    Ravichandran, A.
    Basu, S.
    Nayanala, S.
    Vishwanath, D.
    Muniyappa, N.
    Neelagandan, B. G. K.
    Ramkumar, A. N. J. A.
    Sajjad, S.
    Nair, R. H. J. J.
    Krishnan, G.
    Ramanathan, V. G. R. A.
    Chatterjee, A.
    Sridharan, S.
    Phalke, S.
    Veeramachaneni, V.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S106 - S106
  • [9] Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics
    Witz, Andrea
    Dardare, Julie
    Betz, Margaux
    Michel, Cassandra
    Husson, Marie
    Gilson, Pauline
    Merlin, Jean-Louis
    Harle, Alexandre
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [10] HOMOLOGOUS RECOMBINATION DEFICIENCY TESTING IN ADVANCED OVARIAN CANCER: DESCRIPTION OF THE ENGOT HRD EUROPEAN INITIATIVE
    Pujade-Lauraine, E.
    Christinat, Y.
    D'incalci, M.
    Schouten, P.
    Buisson, A.
    Heukamp, L. C.
    Van Gorp, T.
    Kramer, C.
    Mckee, T.
    Marchini, S.
    Hahnen, E.
    Saintigny, P.
    Braicu, E. Ioana
    Vergote, I. B.
    Yaniz-Galende, E.
    Ray-Coquard, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A208 - A208
12345